GlaxoSmithKline Pharmaceuticals shares hits 20% upper circuit as profit jumps fivefold in Q3FY25

GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in net profit to ₹230 crore and 18% revenue growth to ₹949.42 crore, benefiting from the absence of one-time charges.